Optimal combination of microcoils, flow control, and n-butyl cyanoacrylate–Lipiodol–iopamidol (2:3:1) for feasible embolization of medium-sized arteries in an in vitro vascular model

Combining sparse coiling with NLI231 may be feasible but is limited to use when flow control is available, or where distal embolization is permissible to some extent.

Authors

Takeshi Suzuki (ORCID: https://orcid.org/0000-0002-3040-0625)
Yasunari Fujinaga (ORCID: https://orcid.org/0000-0002-3752-257X)
Masahiro Kurozumi (ORCID: https://orcid.org/0000-0002-5884-2281)
Yoshinori Tsukahara
Akira Yamada (ORCID: https://orcid.org/0000-0002-4199-203X)
Ayumi Ohya (ORCID: https://orcid.org/0000-0003-0786-7531)
Jun Matsuda

Institutions

Shinshu University (JP)

Publication Details

Journal: Japanese Journal of Radiology
Published: 2024-09-28
DOI: https://doi.org/10.1007/s11604-024-01667-4
Citations: 2
Primary Topic: Vascular Malformations Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.74

Optimal combination of microcoils, flow control, and n-butyl cyanoacrylate–Lipiodol–iopamidol (2:3:1) for feasible embolization of medium-sized arteries in an in vitro vascular model

Authors

Institutions

Publication Details

Optimal combination of microcoils, flow control, and n-butyl cyanoacrylate–Lipiodol–iopamidol (2:3:1) for feasible embolization of medium-sized arteries in an in vitro vascular model

Optimal combination of microcoils, flow control, and n-butyl cyanoacrylate–Lipiodol–iopamidol (2:3:1) for feasible embolization of medium-sized arteries in an in vitro vascular model

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.